Published January 27, 2011 | Version v1
Patent Open

ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases.

Files

US20110020340.pdf

Files (1.1 MB)

Name Size Download all
md5:bc926495d06b1aade99906df7ecf3c09
1.1 MB Preview Download

Additional details

Identifiers

Patent number
US 2011/0020340 A1
Patent application number
US 59994608 A
Other
oai:uchicago.tind.io:6689

Dates

Patent filed
2008-05-14

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pathology